amantadine has been researched along with Avian Flu in 36 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vaccines have been used in avian influenza (AI) control programs to prevent, manage or eradicate AI from poultry and other birds." | 2.45 | Avian influenza vaccines and therapies for poultry. ( Swayne, DE, 2009) |
| "In the advent of an influenza virus pandemic it is likely that the administration of antiviral drugs will be an important first line of defence against the virus." | 2.44 | Antiviral drugs for the control of pandemic influenza virus. ( Sugrue, RJ; Sutejo, R; Tan, BH; Yeo, DS, 2008) |
| "The widespread epidemic of avian influenza in domestic birds increases the likelihood for mutational events and genetic reassortment." | 2.42 | Avian influenza: a new pandemic threat? ( Baddour, LM; Prabhu, RM; Smith, TF; Trampuz, A, 2004) |
| "However, several highly pathogenic avian influenza viruses show amantadine-resistance mutations in the viral matrix 2 (M2) protein." | 1.72 | Abuse of amantadine in poultry may be associated with higher fatality rate of H5N1 infections in humans. ( Fu, YF; Hu, J; Jiang, SC; Li, ZL; Yuan, S; Zhang, ZW; Zhu, F, 2022) |
| "Antiviral susceptibility screening of avian influenza (AI) H9N2 viruses is crucial considering their role at the animal-human interface and potential to cause human infections." | 1.51 | Amantadine resistance markers among low pathogenic avian influenza H9N2 viruses isolated from poultry in India, during 2009-2017. ( Keng, SS; Kode, SS; Mullick, J; Pawar, SD; Tare, DS, 2019) |
| " Two groups received either 20 or 40 µl/kg body weight/day Zataria multiflora essential oils (ZM) seven days before the challenge while two other groups received the essential oil at the same dosage but after H9N2 challenge." | 1.48 | Zataria multiflora essential oil reduces replication rate of avian influenza virus (H9N2 subtype) in challenged broiler chicks. ( Barin, A; Ghalyanchilangeroudi, A; Karimi, V; Shayeganmehr, A; Vasfi Marandi, M, 2018) |
| "Highly pathogenic avian influenza (HPAI) H5N1 virus continues to undergo substantial evolution." | 1.43 | Re-emergence of amantadine-resistant variants among highly pathogenic avian influenza H5N1 viruses in Egypt. ( Ali, MA; Bagato, O; El-Shesheny, R; Hassanneen, HM; Kandeil, A; Kayali, G; Mahmoud, SH; Mostafa, A; Webby, RJ, 2016) |
| "Low pathogenic avian influenza virus of subtype H9N2 is panzootic in multiple avian species causing respiratory manifestations and severe economic losses." | 1.42 | Isolation and full genome characterization of avian influenza subtype H9N2 from poultry respiratory disease outbreak in Egypt. ( Abd Elrazek, A; Halami, MY; Heenemann, K; Ibrahim, M; Parvin, R; Shehata, AA; Sultan, H; Talaat, S; Vahlenkamp, T, 2015) |
| "Highly pathogenic H5N1 avian influenza viruses have spread in poultry and wild birds in Asia, Europe, and Africa since 2003." | 1.40 | Characterization of the amantadine-resistant H5N1 highly pathogenic avian influenza variants isolated from quails in Southern China. ( Dong, G; He, H; Ji, G; Luo, J; Peng, C; Wu, B; Zhou, K, 2014) |
| "Our results showed that most of avian influenza viruses were amantadine resistant, Mutations V27I and S31N were founded in these isolates." | 1.36 | [Detection of molecular markers of amantadine resistance in avian influenza viruses by pyrosequencing]. ( Li, JM; Liu, HL; Lv, Y; Sun, CY; Wang, ZL; Zhang, W; Zhao, YL; Zheng, DX, 2010) |
| "Resistance of influenza viruses to antiviral drugs can emerge following medication or may result from natural variation." | 1.35 | Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. ( Balish, A; Bright, RA; Deyde, VM; Gubareva, LV; Klimov, AI; Lindstrom, S; Nguyen, T; Shu, B, 2009) |
| "Matrix (M) protein genes of 17 H9N2 avian influenza viruses (AIVs) isolated from chickens in northern China during the last 10 years were completely sequenced and phylogenetically analyzed." | 1.35 | Evolution analysis of the matrix (M) protein genes of 17 H9N2 chicken influenza viruses isolated in northern China during 1998-2008. ( Cao, S; Hu, B; Huang, Y; Khan, MI; Wen, X; Xu, D; Zhang, X, 2009) |
| "Since 2003, highly pathogenic A(H5N1) influenza viruses have been the cause of large-scale death in poultry and the subsequent infection and death of over 140 humans." | 1.34 | Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. ( Barr, IG; Brown, L; Hurt, AC; Komadina, N; Selleck, P; Shaw, R, 2007) |
| "These six influenza isolates were obtained from four different provinces of Thailand during the avian influenza outbreak in Asia from late 2003 to May 2004." | 1.33 | Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. ( Auewarakul, P; Boonnak, K; Charoenying, PC; Khanyok, R; Kijphati, R; Pooruk, P; Puthavathana, P; Sangsiriwut, K; Sawanpanyalert, P; Thawachsupa, P, 2005) |
| "To analyze the compatibility of avian influenza A virus hemagglutinins (HAs) and human influenza A virus matrix (M) proteins M1 and M2, we doubly infected Madin-Darby canine kidney cells with amantadine (1-aminoadamantane hydrochloride)-resistant human viruses and amantadine-sensitive avian strains." | 1.31 | Cooperation between the hemagglutinin of avian viruses and the matrix protein of human influenza A viruses. ( Krauss, S; Scholtissek, C; Stech, J; Webster, RG, 2002) |
| "Amantadine has been accepted for both the treatment and prophylaxis of influenza A virus infections." | 1.28 | Biologic potential of amantadine-resistant influenza A virus in an avian model. ( Bean, WJ; Threlkeld, SC; Webster, RG, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (58.33) | 29.6817 |
| 2010's | 12 (33.33) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Yuan, S | 1 |
| Jiang, SC | 1 |
| Zhang, ZW | 1 |
| Fu, YF | 1 |
| Zhu, F | 1 |
| Li, ZL | 1 |
| Hu, J | 1 |
| Kode, SS | 1 |
| Pawar, SD | 1 |
| Tare, DS | 1 |
| Keng, SS | 1 |
| Mullick, J | 1 |
| Shayeganmehr, A | 1 |
| Vasfi Marandi, M | 1 |
| Karimi, V | 1 |
| Barin, A | 1 |
| Ghalyanchilangeroudi, A | 1 |
| Xie, S | 1 |
| Wen, K | 1 |
| Xie, J | 1 |
| Zheng, Y | 1 |
| Peng, T | 1 |
| Wang, J | 1 |
| Yao, K | 1 |
| Ding, S | 1 |
| Jiang, H | 1 |
| Dong, G | 1 |
| Luo, J | 1 |
| Zhou, K | 1 |
| Wu, B | 1 |
| Peng, C | 1 |
| Ji, G | 1 |
| He, H | 1 |
| Tosh, C | 2 |
| Nagarajan, S | 2 |
| Murugkar, HV | 2 |
| Kumar, M | 1 |
| Pandey, M | 1 |
| Jolhe, DK | 1 |
| Tripathi, S | 2 |
| Shukla, S | 1 |
| Ved, N | 1 |
| Mishra, A | 1 |
| Ghosh, RC | 1 |
| Kulkarni, DD | 2 |
| Shehata, AA | 1 |
| Parvin, R | 1 |
| Sultan, H | 1 |
| Halami, MY | 1 |
| Talaat, S | 1 |
| Abd Elrazek, A | 1 |
| Ibrahim, M | 1 |
| Heenemann, K | 1 |
| Vahlenkamp, T | 1 |
| Naguib, MM | 1 |
| Hagag, N | 1 |
| El-Sanousi, AA | 1 |
| Hussein, HA | 1 |
| Arafa, AS | 1 |
| El-Shesheny, R | 1 |
| Bagato, O | 1 |
| Kandeil, A | 1 |
| Mostafa, A | 1 |
| Mahmoud, SH | 1 |
| Hassanneen, HM | 1 |
| Webby, RJ | 1 |
| Ali, MA | 1 |
| Kayali, G | 1 |
| Abdelwhab, EM | 1 |
| Veits, J | 1 |
| Mettenleiter, TC | 1 |
| Sugrue, RJ | 1 |
| Tan, BH | 1 |
| Yeo, DS | 1 |
| Sutejo, R | 1 |
| Lee, J | 1 |
| Song, YJ | 1 |
| Park, JH | 1 |
| Lee, JH | 1 |
| Baek, YH | 1 |
| Song, MS | 1 |
| Oh, TK | 1 |
| Han, HS | 1 |
| Pascua, PN | 1 |
| Choi, YK | 1 |
| Deyde, VM | 1 |
| Nguyen, T | 1 |
| Bright, RA | 1 |
| Balish, A | 1 |
| Shu, B | 1 |
| Lindstrom, S | 1 |
| Klimov, AI | 1 |
| Gubareva, LV | 1 |
| Huang, Y | 1 |
| Hu, B | 1 |
| Wen, X | 1 |
| Cao, S | 1 |
| Xu, D | 1 |
| Zhang, X | 1 |
| Khan, MI | 1 |
| Kwon, YK | 1 |
| Kwon, KY | 1 |
| Joh, SJ | 1 |
| Kim, MC | 1 |
| Kang, MS | 1 |
| Lee, YJ | 1 |
| Kwon, JH | 1 |
| Kim, JH | 1 |
| Katare, M | 1 |
| Jain, R | 1 |
| Khandia, R | 1 |
| Syed, Z | 1 |
| Behera, P | 1 |
| Patil, S | 1 |
| Dubey, SC | 1 |
| Liu, HL | 1 |
| Lv, Y | 1 |
| Zheng, DX | 1 |
| Zhao, YL | 1 |
| Sun, CY | 1 |
| Zhang, W | 1 |
| Li, JM | 1 |
| Wang, ZL | 1 |
| Trampuz, A | 1 |
| Prabhu, RM | 1 |
| Smith, TF | 1 |
| Baddour, LM | 1 |
| Suzuki, H | 1 |
| Puthavathana, P | 1 |
| Auewarakul, P | 1 |
| Charoenying, PC | 1 |
| Sangsiriwut, K | 1 |
| Pooruk, P | 1 |
| Boonnak, K | 1 |
| Khanyok, R | 1 |
| Thawachsupa, P | 1 |
| Kijphati, R | 1 |
| Sawanpanyalert, P | 1 |
| Normile, D | 1 |
| Enserink, M | 1 |
| Sauerbrei, A | 1 |
| Haertl, A | 1 |
| Brandstaedt, A | 1 |
| Schmidtke, M | 1 |
| Wutzler, P | 1 |
| Ilyushina, NA | 1 |
| Govorkova, EA | 1 |
| Webster, RG | 6 |
| Cheung, CL | 1 |
| Rayner, JM | 1 |
| Smith, GJ | 1 |
| Wang, P | 1 |
| Naipospos, TS | 1 |
| Zhang, J | 1 |
| Yuen, KY | 1 |
| Peiris, JS | 1 |
| Guan, Y | 1 |
| Chen, H | 1 |
| Luo, RP | 1 |
| Zhu, YM | 1 |
| Xu, ZY | 1 |
| Gao, JP | 1 |
| Yu, SJ | 1 |
| Hurt, AC | 1 |
| Selleck, P | 1 |
| Komadina, N | 1 |
| Shaw, R | 1 |
| Brown, L | 1 |
| Barr, IG | 1 |
| Aamir, UB | 1 |
| Wernery, U | 1 |
| Ilyushina, N | 1 |
| Chutinimitkul, S | 1 |
| Songserm, T | 1 |
| Amonsin, A | 1 |
| Payungporn, S | 1 |
| Suwannakarn, K | 1 |
| Damrongwatanapokin, S | 1 |
| Chaisingh, A | 1 |
| Nuansrichay, B | 1 |
| Chieochansin, T | 1 |
| Theamboonlers, A | 1 |
| Poovorawan, Y | 1 |
| He, G | 1 |
| Qiao, J | 1 |
| Dong, C | 1 |
| He, C | 1 |
| Zhao, L | 1 |
| Tian, Y | 1 |
| Swayne, DE | 1 |
| Scholtissek, C | 1 |
| Stech, J | 1 |
| Krauss, S | 1 |
| Bean, WJ | 2 |
| Threlkeld, SC | 1 |
| Kawaoka, Y | 1 |
| Beard, CW | 1 |
| Brugh, M | 1 |
4 reviews available for amantadine and Avian Flu
| Article | Year |
|---|---|
Antiviral drugs for the control of pandemic influenza virus.
Topics: Amantadine; Animals; Antiviral Agents; Birds; Disease Outbreaks; Global Health; Humans; Influenza A | 2008 |
Avian influenza: a new pandemic threat?
Topics: Amantadine; Animals; Antiviral Agents; Asia; Communicable Diseases, Emerging; Disease Outbreaks; Dru | 2004 |
[Super pathogenic avian influenza].
Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Chickens; Disease Outbreaks; Guanidines; Humans; | 2004 |
Avian influenza vaccines and therapies for poultry.
Topics: Amantadine; Animals; Antiviral Agents; Birds; Cloning, Molecular; Genetic Vectors; Hemagglutinin Gly | 2009 |
32 other studies available for amantadine and Avian Flu
| Article | Year |
|---|---|
Abuse of amantadine in poultry may be associated with higher fatality rate of H5N1 infections in humans.
Topics: Amantadine; Animals; Antiviral Agents; Birds; Drug Resistance, Viral; Humans; Influenza A Virus, H5N | 2022 |
Amantadine resistance markers among low pathogenic avian influenza H9N2 viruses isolated from poultry in India, during 2009-2017.
Topics: Amantadine; Animals; Antiviral Agents; Birds; Chickens; Drug Resistance, Viral; Genetic Markers; Ind | 2019 |
Zataria multiflora essential oil reduces replication rate of avian influenza virus (H9N2 subtype) in challenged broiler chicks.
Topics: Amantadine; Animal Feed; Animals; Antiviral Agents; Chickens; Diet; Dietary Supplements; Dose-Respon | 2018 |
Magnetic-assisted biotinylated single-chain variable fragment antibody-based immunoassay for amantadine detection in chicken.
Topics: Amantadine; Animals; Antiviral Agents; Biotin; Chickens; Chromatography, High Pressure Liquid; Cross | 2018 |
Characterization of the amantadine-resistant H5N1 highly pathogenic avian influenza variants isolated from quails in Southern China.
Topics: Amantadine; Animals; Antiviral Agents; China; Cluster Analysis; Drug Resistance, Viral; Evolution, M | 2014 |
Emergence of Val27Ala mutation in M2 protein associated with amantadine resistance in highly pathogenic avian influenza H5N1 viruses in India.
Topics: Amantadine; Animals; Antiviral Agents; Birds; Drug Resistance, Viral; India; Influenza A Virus, H5N1 | 2014 |
Isolation and full genome characterization of avian influenza subtype H9N2 from poultry respiratory disease outbreak in Egypt.
Topics: Amantadine; Animals; Antiviral Agents; Chickens; Cluster Analysis; Disease Outbreaks; Drug Resistanc | 2015 |
The matrix gene of influenza A H5N1 in Egypt, 2006-2016: molecular insights and distribution of amantadine-resistant variants.
Topics: Amantadine; Animals; Antiviral Agents; Chickens; Drug Resistance, Viral; Egypt; Genotype; History, 2 | 2016 |
Re-emergence of amantadine-resistant variants among highly pathogenic avian influenza H5N1 viruses in Egypt.
Topics: Amantadine; Animals; Antiviral Agents; Drug Resistance, Viral; Egypt; Genetic Variation; Influenza A | 2016 |
Biological fitness and natural selection of amantadine resistant variants of avian influenza H5N1 viruses.
Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Chickens; Drug Resistance, Viral; Egypt; Genetic F | 2017 |
Emergence of amantadine-resistant H3N2 avian influenza A virus in South Korea.
Topics: Amantadine; Amino Acid Substitution; Animals; Antiviral Agents; Drug Resistance, Viral; Influenza A | 2008 |
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.
Topics: Amantadine; Animals; Antiviral Agents; Birds; Drug Resistance, Viral; Genetic Markers; Humans; Influ | 2009 |
Evolution analysis of the matrix (M) protein genes of 17 H9N2 chicken influenza viruses isolated in northern China during 1998-2008.
Topics: Amantadine; Amino Acid Substitution; Animals; Antiviral Agents; Chickens; China; Cluster Analysis; D | 2009 |
The susceptibility of magpies to a highly pathogenic avian influenza virus subtype H5N1.
Topics: Amantadine; Animals; Disease Susceptibility; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Pa | 2010 |
Emergence of amantadine-resistant avian influenza H5N1 virus in India.
Topics: Amantadine; Amino Acid Substitution; Animals; Asparagine; Chickens; Disease Outbreaks; Drug Resistan | 2011 |
[Detection of molecular markers of amantadine resistance in avian influenza viruses by pyrosequencing].
Topics: Amantadine; Animals; Antiviral Agents; Chickens; Drug Resistance, Viral; Influenza A virus; Influenz | 2010 |
Avian influenza should be ruffling our feathers.
Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Asia, Eastern; Asia, Southeastern; Birds; Disease | 2004 |
Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand.
Topics: Amantadine; Animals; Antiviral Agents; Chickens; Disease Outbreaks; Drug Resistance, Viral; Hemagglu | 2005 |
Statement on influenza vaccination for the 2005-2006 season. An advisory committee statement.
Topics: Acetamides; Adolescent; Age Factors; Amantadine; Animals; Antiviral Agents; Canada; Child; Child, Pr | 2005 |
Infectious diseases. Lapses worry bird flu experts.
Topics: Amantadine; Animals; Antiviral Agents; Asia; Chickens; Disease Outbreaks; Drug Resistance, Viral; Hu | 2005 |
Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Chick Embryo; Chickens; Enzyme Inhibitors; Guanid | 2006 |
Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia.
Topics: Amantadine; Animals; Antiviral Agents; Asia, Southeastern; Cell Line; Dogs; Drug Resistance, Viral; | 2005 |
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.
Topics: Amantadine; Amino Acid Substitution; Animals; Antiviral Agents; Asia; Birds; Drug Resistance, Viral; | 2006 |
[Report of the first human case of H5N1 avian influenza pneumonia in Hunan, China].
Topics: Amantadine; Animals; Antibodies, Viral; Antiviral Agents; Birds; Child; China; Glucocorticoids; Huma | 2006 |
Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS).
Topics: Acetamides; Adolescent; Adult; Aged; Amantadine; Animals; Antiviral Agents; Canada; Child; Child, Pr | 2006 |
Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
Topics: Acids, Carbocyclic; Amantadine; Animals; Antiviral Agents; Base Sequence; Birds; Cyclopentanes; Drug | 2007 |
Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003.
Topics: Amantadine; Amino Acid Substitution; Animals; Antigens, Viral; Antiviral Agents; Chickens; Disease O | 2007 |
New strain of influenza A virus (H5N1), Thailand.
Topics: Amantadine; Animals; Antigens, Viral; Antiviral Agents; Chickens; Disease Outbreaks; Genes, Viral; G | 2007 |
Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China.
Topics: Amantadine; Animals; Antiviral Agents; Base Sequence; Cell Line; Chickens; China; Drug Resistance, V | 2008 |
Cooperation between the hemagglutinin of avian viruses and the matrix protein of human influenza A viruses.
Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Dogs; Drug Resistance, Viral; Hemagglutinin Glycop | 2002 |
Biologic potential of amantadine-resistant influenza A virus in an avian model.
Topics: Amantadine; Animals; Chickens; Drug Resistance, Microbial; Female; Influenza A virus; Influenza in B | 1989 |
Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus.
Topics: Adamantane; Amantadine; Animals; Chickens; Drug Resistance, Microbial; Influenza A virus; Influenza | 1985 |